Skip to main content
    V

    Viatris Inc (VTRS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $20.74
    -0.08 (-0.38%)

    Market Cap: $23.87B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Viatris Inc (VTRS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Viatris are United Therapeutics (UTHR), Zoetis (ZTS) and Teva Pharma Industries Ltd ADR (TEVA). Viatris trades at 8.1x earnings, against a median of 19.9x for the 10 of these companies with a P/E. By market cap, Viatris ranks 6th of the 13 companies on this page; Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest at $68.47B.

    Peer Comparison

    VTRS's ROIC of -0.2% is below the peer median of 11.6%, and its revenue growth of -0.3% is below the median of 5.4%. It yields 2.31%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Viatris (VTRS)$23.87B8.1x1.6x-4.1%-0.2%-0.3%2.31%
    United Therapeutics Corporation (UTHR)$25.18B22.2x7.9x38.6%N/A4.1%0.00%
    Zoetis Inc (ZTS)$34.06B12.7x3.7x26.4%21.7%-1.3%2.51%
    Teva Pharma Industries Ltd ADR (TEVA)$51.92B14.4x2.9x2.9%4.3%-1.9%0.00%
    Neurocrine Biosciences Inc (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    Elanco Animal Health (ELAN)$13.39B23.2x2.6x-2.9%1.6%11.3%0.00%
    Haleon plc (HLN)$40.25BN/A1.6x14.5%13.9%2.2%2.12%
    Dr. Reddy’s Laboratories Ltd ADR (RDY)$12.29B39.6x3.5x8.5%5.7%-1.5%0.44%
    Takeda Pharmaceutical Co Ltd ADR (TAK)$68.47BN/A2.3x0.9%5.6%6.7%2.92%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Lantheus Holdings Inc (LNTH)$6.64B17.9x4.5x17.3%14.8%1.5%0.00%
    Indivior PLC Ordinary Shares (INDV)$4.28B6.6x2.4x32.8%109.0%13.4%0.00%
    Kiniksa Pharmaceuticals Ltd (KNSA)$7.57B72.5x7.8x11.6%N/A58.1%0.00%
    Peer median$15.16B19.9x3.2x13.1%11.6%5.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Viatris, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    United Therapeutics Corporation (UTHR)
    United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs...
    UTHR competitors
    Zoetis Inc (ZTS)
    Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
    ZTS competitors
    Teva Pharma Industries Ltd ADR (TEVA)
    Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs...
    TEVA competitors
    Neurocrine Biosciences Inc (NBIX)
    Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological...
    NBIX competitors
    Elanco Animal Health (ELAN)
    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals.
    ELAN competitors
    Haleon plc (HLN)
    Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline...
    Dr. Reddy’s Laboratories Ltd ADR (RDY)
    Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
    RDY competitors
    Takeda Pharmaceutical Co Ltd ADR (TAK)
    Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals...
    TAK competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors
    Lantheus Holdings Inc (LNTH)
    Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment...
    LNTH competitors
    Indivior PLC Ordinary Shares (INDV)
    Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence...
    Kiniksa Pharmaceuticals Ltd (KNSA)
    Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical...
    KNSA competitors

    Frequently Asked Questions About VTRS

    Who are Viatris' main competitors?

    The companies most similar to Viatris include United Therapeutics (UTHR), Zoetis (ZTS), Teva Pharma Industries Ltd ADR (TEVA), Neurocrine Biosciences (NBIX) and Elanco Animal Health (ELAN), listed from the closest match.

    Who is Viatris' biggest competitor?

    Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest of the similar companies at $68.47B; United Therapeutics (UTHR) is the closest match by business profile, size, sector and industry.

    How does VTRS stock compare with its competitors?

    VTRS' P/E is 8.1x against a peer median of 19.9x; its P/S is 1.6x against a peer median of 3.2x; its net margin is -4.1% against a peer median of 13.1%.

    Which of Viatris' competitors pays a higher dividend?

    Viatris has a forward dividend yield of 2.31%. Takeda Pharmaceutical Co Ltd ADR (TAK) and Zoetis (ZTS) have higher forward dividend yields; Takeda Pharmaceutical Co Ltd ADR (TAK) has the highest at 2.92%.

    Is Viatris bigger than its competitors?

    No. Viatris is 6th by market cap among the 13 companies on this page; the largest is Takeda Pharmaceutical Co Ltd ADR (TAK) at $68.47B.